[ET Net News Agency, 31 March 2022] Sino Biopharmaceutical Limited (01177) said its
profit attributable to owners of the parent was RMB14.61 billion for the year ended 31
December 2021, a year-on-year increase of 427.2%. A final dividend of HK4 cents per share
will be distributed.
Revenue was RMB26.86 billion, a year-on-year increase of 13.6%. (RC)